Mpox vaccine is safe and generates a robust antibody response in adolescents
On Oct. 16, 2024, a National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Life Science News | Therapeutics | Vaccine
New risks raise pandemic threat on a global scale
On Oct. 14, 2024, the Global Preparedness Monitoring Board (GPMB) released a report that outlined 15 key drivers…
RedHill Biopharma Secured U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment
On Oct. 14, 2024, RedHill Biopharma announced that the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA)…
Sabin Vaccine Institute Sent Additional Vaccines to Rwanda for Marburg Outbreak
On Oct. 12, 2024, the Sabin Vaccine Institute announced it had delivered approximately 1,000 more investigational vaccine doses…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Therapeutics | WHO
WHO reported Increase in Rwanda Marburg virus disease incidence
On Oct. 11, 2024, the World Health Organization (WHO) reported that a total of 58 cases of Marburg…
New virus uncovered in China – increased threat of tick-borne diseases
On Oct. 11, 2024, researchers in China published a study that provided details about a new wetland virus….
U.S. officials reported Cluster of drug-resistant mpox identified in five states
On Oct. 10, 2024, health officials from the U.S. Centers for Disease Control and Prevention announced they had…
Suspected Outbreak of Trichinellosis in North Carolina Associated with Undercooked Bear Meat
On Oct. 10, 2024, the U.S. Centers for Disease Control and Prevention announced that a 2023 presumed outbreak…
WHO report elevates role of vaccines in addressing antimicrobial resistance
On Oct. 10, 2024, a report by the World Health Organization (WHO) found that vaccines against 24 pathogens…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Neurology | NIH | Non-Profit Research | Therapeutics | Vaccine
Study Found Persistent Infection Could Explain Long COVID in Some People
On Oct. 9, 2024, researchers from Brigham and Women’s Hospital found that people with wide-ranging long COVID symptoms…
Viruses thrive on your toothbrush and showerhead
On Oct. 9, 2024, in a Northwestern University-led study, microbiologists found that showerheads and toothbrushes were teeming with…
Novavax’s Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Received Authorization in the EU
On Oct. 9, 2024, Novavax announced that the European Commission had granted Marketing Authorization for Novavax’s updated 2024-2025…
Annual dengue cases double, PAHO urged countries to strengthen response as seasonal transmission began in South America
On Oct. 8, 2024, the Pan American Health Organization (PAHO) announced an epidemiological alert and urged countries in…
San Diego County Reported First Locally Acquired Dengue Case
On Oct. 6, 2024, San Diego County officials announced they were investigating the first ever case of locally…
Sabin Vaccine Institute Delivered Marburg Vaccines to Combat Outbreak in Rwanda
On Oct. 5, 2024, the Sabin Vaccine Institute announced it had provided its investigational Marburg vaccine to Rwanda…
Oxford Researchers Received Funding to create world’s first ovarian cancer prevention vaccine
On Oct. 4, 2024, researchers from Oxford university announced they had been awarded funding from Cancer Research UK…
WHO added an HPV vaccine for single-dose use
On Oct. 4, 2024, the World Health Organization (WHO) announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
COVID-19 hospitalization remained higher among older adults
On Oct. 4, 2024, the Centers for Disease Control and Prevention (CDC) published data that showed older adults…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Therapeutics | Vaccine | WHO
WHO launches global strategic plan to fight rising dengue and other Aedes-borne arboviral diseases
On Oct. 3, 2024,the World Health Organization (WHO) launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP)…
WHO approved first mpox diagnostic test for emergency use, boosting global access
On Oct. 3, 2024, the World Health Organization (WHO) announced it had listed the first mpox in vitro…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | WHO
MERS coronavirus case reported in Saudi Arabia
On Oct. 2, 2024, the World Health Organization (WHO) announced it had been notified of one human case…
Biotechnology | Diagnostics | Environmental | Genomics | Infectious Disease | Life Science News | Medical Device | Nanotechnology | Oncology | Therapeutics | U.S. Congress
Strengthening the U.S. Biomedical Research Enterprise Entails National Strategic Coordination, Focus on Health Equity
On Oct. 1, 2024, the National Academy of Medicine (NAM) announced a study showing that although the U.S….
Rwanda reports first-ever Marburg virus disease outbreak, with 26 cases confirmed
On Sept. 28, 2024, the World Health Organization (WHO) announced that Rwandan health authorities were intensifying outbreak control…
Superbugs could jeopardise food security for over two billion people and increase annual health care costs by U.S. $159 billion annually by 2050, finds most extensive modelling to date
On Sept. 25, 2024, drug-resistant pathogens could jeopardise the food supply of over two billion people and increase…
COVID-19 Symptoms Reduced Among U.S. Healthcare Personnel Receiving Additional Vaccine Doses
On Sept. 25, 2024, U.S. healthcare workers receiving additional vaccine doses during the Omicron period (December 2021 to…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | NIH | Therapeutics | U.S. Congress
Mark O. Hatfield Clinical Research Center at the National Institutes of Health dedicated
On Sept. 24, 2024, the Mark O. Hatfield Clinical Research Center at the National Institutes of Health (NIH)…
White House announced 1 million vaccine doses for Africa’s mpox response
On Sept. 24, 2024, U.S. President Joe Biden announced the donation of 1 million mpox vaccine doses and…
Oxitec Launched Sparks™, a Commercial Platform to Scale Dengue-Blocking Wolbachia Solution, Aiming to Protect One Billion People by 2040
On Sept. 19, 2024, Oxitec announced it had launched Sparks™, a new commercial platform to accelerate the global…
Focus on Lyme announced launch of Lyme Disease Test with Over 90% Accuracy
On Sept. 19, 2024, the nonprofit organization Focus on Lyme and Aces Diagnostics announced a breakthrough in Lyme…
EMA recommended extending indication of mpox vaccine to adolescents
On Sept. 19, 2024, the European Medical Agency (EMA) announced it had recommended extending the indication of the…